Sartorelli's group has shown that inhibitors of GSK-3 prevent ATRA-mediated degradation of RARα, thereby potentiating ATRA-stimulated differentiation of AML cell lines [88, 89]. The gene discussed is RARA; the disease is acute myeloid leukemia.